Clinical Trial Update: Predicting Stroke Risk in ICAD With Novel MRI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing a novel MRI approach to predict stroke risk in intracranial atherosclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Atherosclerosis

Snippet

Sponsor: Northwestern University | Conditions: Intracranial Atherosclerosis | Phase 4 | Status: COMPLETED